Predicted protein targets (top 20)
| gene | UniProt | supporting neighbours | confidence | |
|---|---|---|---|---|
| ▸ | TDP1 | Q9NUW8 | 1/20 | 0.59 |
| ▸ | KDM4E | B2RXH2 | 1/20 | 0.56 |
| ▸ | NPC1 | O15118 | 1/20 | 0.56 |
| ▸ | CYP11B1 | P15538 | 4/20 | 0.53 |
| ▸ | CYP11B2 | P19099 | 4/20 | 0.53 |
| ▸ | TNF | P01375 | 1/20 | 0.53 |
| ▸ | SMN1; SMN2 | Q16637 | 4/20 | 0.51 |
| ▸ | LMNA | P02545 | 3/20 | 0.51 |
| ▸ | HTT | P42858 | 3/20 | 0.51 |
| ▸ | L3MBTL1 | Q9Y468 | 2/20 | 0.51 |
| ▸ | EGLN3 | Q9H6Z9 | 1/20 | 0.51 |
| ▸ | APAF1 | O14727 | 1/20 | 0.51 |
| ▸ | CYP3A4 | P08684 | 1/20 | 0.50 |
| ▸ | CYP2D6 | P10635 | 1/20 | 0.50 |
| ▸ | CYP2C9 | P11712 | 1/20 | 0.50 |
| ▸ | CYP2C19 | P33261 | 1/20 | 0.50 |
| ▸ | ALPL | P05186 | 1/20 | 0.50 |
| ▸ | ALPI | P09923 | 1/20 | 0.50 |
| ▸ | ALPG | P10696 | 1/20 | 0.50 |
| ▸ | PLAA | Q9Y263 | 1/20 | 0.50 |
Click a target to see other patent compounds predicted against it — the reverse direction, in place.
Similar compounds — the chemically nearest patent molecules
Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.
| Compound | similarity | top predicted | shared targets | |
|---|---|---|---|---|
| SCHEMBL27864830 | 0.86 | TDP1 (0.63) | TDP1KDM4ENPC1CYP11B1CYP11B2 | |
| SCHEMBL7160203 | 0.84 | TDP1 (0.61) | TDP1KDM4ENPC1CYP11B1CYP11B2 | |
| SCHEMBL10881570 | 0.83 | KDM4E (0.65) | TDP1KDM4ENPC1SMN1; SMN2LMNA | |
| SCHEMBL26818584 | 0.83 | KDM4E (0.60) | TDP1KDM4ENPC1CYP11B1CYP11B2 | |
| SCHEMBL7732690 | 0.83 | TDP1 (0.59) | TDP1KDM4ENPC1CYP11B1CYP11B2 | |
| SCHEMBL11498670 | 0.82 | KDM4E (0.56) | TDP1KDM4ENPC1CYP11B1CYP11B2 | |
| SCHEMBL8017568 | 0.80 | TDP1 (0.56) | TDP1KDM4ENPC1CYP11B1CYP11B2 | |
| SCHEMBL1035783 | 0.77 | EGLN3 (0.71) | TDP1KDM4ENPC1CYP11B1CYP11B2 | |
| SCHEMBL4284703 | 0.77 | KDM4E (0.61) | TDP1KDM4ENPC1SMN1; SMN2LMNA | |
| Hydrogen Sulfide SCHEMBL28767930 | 0.76 | EGLN3 (0.69) | TDP1KDM4ENPC1CYP11B1CYP11B2 |
Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.
Patent provenance — the patents this molecule appears in, and who filed them
Claimed or disclosed in 22 patents — showing the first 20. claimed = in the patent's claims; disclosed = body only.
| Patent | Title | Assignee | Published | Priority | Filing | Country | Status |
|---|---|---|---|---|---|---|---|
| CN-114907514-A | Multifunctional fiber and preparation method and application thereof | 北京洁尔爽高科技有限公司 | 2022-08-16 | — | — | CN | disclosed |
| EP-2570418-A2 | 2,3-dihydro-6-nitroimidazo[2,1-b]oxazoles compound | OTSUKA PHARMACEUTICAL CO., LTD. (JP) | 2013-03-20 | — | — | EP | disclosed |
| EP-1555267-B1 | 2,3-DIHYDRO-6-NITROIMIDAZO[2,1-b]OXAZOLES | OTSUKA PHARMA CO LTD (JP) | 2013-01-16 | — | — | EP | disclosed |
| EP-2040666-B1 | BENZIMIDAZOLES AS COOLING COMPOUNDS | GIVAUDAN SA (CH) | 2010-01-20 | — | — | EP | disclosed |
| US-20090312384-A1 | Benzimidazole As Cooling Compounds | GIVAUDAN SA (CH) | 2009-12-17 | — | — | US | disclosed |
| EP-2040666-A2 | BENZIMIDAZOLES AS COOLING COMPOUNDS | Givaudan SA (CH) | 2009-04-01 | — | — | EP | disclosed |
| WO-2008006236-A2 | BENZIMIDAZOLES AS COOLING COMPOUNDS | GIVAUDAN SA (CH) | 2008-01-17 | — | — | WO | disclosed |
| US-7262212-B2 | 2,3-dihydro-6-nitroimidazo[2,1-b]oxazoles | OTSUKA PHARMACEUTICAL CO., LTD. (JP) | 2007-08-28 | — | — | US | disclosed |
| US-20060094767-A1 | 2,3-Dihydro-6-nitroimidazo[2,1-b]oxazoles | OTSUKA PHARMACEUTICAL CO., LTD. (JP) | 2006-05-04 | — | — | US | disclosed |
| EP-1555267-A1 | 2,3-DIHYDRO-6-NITROIMIDAZO 2,1-b OXAZOLES | OTSUKA PHARMACEUTICAL CO., LTD. (JP) | 2005-07-20 | — | — | EP | disclosed |
| EP-0137655-B1 | RADIATION-SENSITIVE POLYMER COMPOSITION | TORAY INDUSTRIES, INC. (JP) | 1988-12-28 | — | — | EP | disclosed |
| US-4783391-A | Radiation-sensitive polyamide polymer composition with anthraquinone monoazide | TORAY INDUSTRIES, INC. (JP) | 1988-11-08 | — | — | US | disclosed |
| EP-0119719-B1 | RADIATION SENSITIVE POLYMER COMPOSITION | TORAY INDUSTRIES, INC. (JP) | 1987-05-06 | — | — | EP | disclosed |
| EP-0214600-A2 | Cephalosporin derivatives | Otsuka Kagaku Kabushiki Kaisha (JP) | 1987-03-18 | — | — | EP | disclosed |
| US-4608333-A | INCREASED PHOTOSENSITIVITY BY INCLUDING AN AROMATIC SECONDARY OR TERTIARY AMINE WITH AN ACRYLIC MONOMER AND A POLYIMIDE-CURING POLYAMIDE | TORAY INDUSTRIES, INC. (JP) | 1986-08-26 | — | — | US | disclosed |
| EP-0137655-A2 | Radiation-sensitive polymer composition | TORAY INDUSTRIES, INC. (JP) | 1985-04-17 | — | — | EP | disclosed |
| EP-0119719-A1 | Radiation sensitive polymer composition | TORAY INDUSTRIES, INC. (JP) | 1984-09-26 | — | — | EP | disclosed |
| US-4243743-A | CARBOXYL-CONTAINING POLYAMIDE, UNSATURATED AMINE OR QUATERNARY AMMONIUM SALT | TORAY INDUSTRIES, INC. (JP) | 1981-01-06 | — | — | US | disclosed |
| US-3956216-A | ACRYLIC ESTER-AZOLIDE-VINYLIDENE POLYMER | THE B. F. GOODRICH COMPANY (US) | 1976-05-11 | — | — | US | disclosed |
| US-3955041-A | AS BINDERS FOR NONWOVEN FIBERS | THE B. F. GOODRICH COMPANY (US) | 1976-05-04 | — | — | US | disclosed |
Patent text — is the patent's own abstract consistent with the prediction?
For each of this compound's patents that has machine-readable text (2 of them — usually the abstract, not the full specification), we ask MedCPT which protein the text reads most about, and where the chemistry-predicted target lands among 4885 human targets. A high rank means the patent's own wording is consistent with the prediction — a weak, independent signal, not proof of activity.
| Patent | Title | Text reads most about | Predicted target · text-rank |
|---|---|---|---|
| US-20090312384-A1 | Benzimidazole As Cooling Compounds | TAS2R41, TAS2R4, TAS2R43 | TDP1 1855/4885KDM4E 4133/4885NPC1 1408/4885 |
| US-20060094767-A1 | 2,3-Dihydro-6-nitroimidazo[2,1-b]oxazoles | NR2C2, NR4A3, NR4A2 | TDP1 4666/4885KDM4E 4854/4885NPC1 2404/4885 |
“Text reads most about” is the patent abstract's nearest protein in MedCPT space (background-debiased). Only ~1.4% of patents have machine-readable text, so most compounds won't have this panel.